☆ 4.8 Article

Rapid and Quantitative In Vitro Evaluation of SARS-CoV-2 Neutralizing Antibodies and Nanobodies

ANALYTICAL CHEMISTRY (2022)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Peter Chen et al.

Summary: LY-CoV555, a neutralizing antibody, showed promising results in reducing viral load, improving symptoms, and lowering the risk of hospitalization among patients with mild or moderate Covid-19. While one of the doses appeared to accelerate the decline in viral load, others did not show significant effects by day 11.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Immunology

S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated With Significantly Higher Viral Load in Samples Tested by TaqPath Polymerase Chain Reaction

Michael Kidd et al.

Summary: Analysis of recent test data shows that samples containing the SARS-CoV-2 variant B1.1.7 with mutation Delta 69/70 exhibit S gene target failure (SGTF) in ThermoFisher TaqPath RT-qPCR. Samples with SGTF profile are more likely to have higher viral loads, indicating higher infectivity and rapid spread of this variant.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Multidisciplinary Sciences

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Pengfei Wang et al.

Summary: The COVID-19 pandemic has had global repercussions, with promising vaccines and monoclonal antibody therapies. However, newly detected variants of SARS-CoV-2 present challenges to these treatment options.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screening

John S. Schardt et al.

Summary: Monoclonal antibodies targeting SARS-CoV-2 are crucial for COVID-19 applications, and single B cell screening has shown potential for rapid and reliable identification of high-affinity, potent neutralizing antibodies. These antibodies, identified through this method, compete with ACE2 for binding to the receptor-binding domain of SARS-CoV-2, suggesting possible future developments for urgent COVID-19 needs.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Cell Biology

SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity

M. Gordon Joyce et al.

Summary: The study designed and characterized four categories of engineered nanoparticle immunogens that induced robust antibodies against SARS-CoV-2, showing effectiveness against different variants and also significant neutralizing antibody titers against SARS-CoV-1. These immunogens demonstrated high protective efficacy in animal experiments, offering new insights for vaccine development and antiviral strategies.

CELL REPORTS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

Markus Hoffmann et al.

Summary: The emerging SARS-CoV-2 variants may exhibit resistance to existing neutralizing antibodies and treatments, which could have significant implications for pandemic containment efforts.

CELL (2021)

Add to Collection

Review Pathology

Rapid lateral flow tests for the detection of SARS-CoV-2 neutralizing antibodies

Jianfu J. Wang et al.

Summary: The article discusses the importance of SARS-CoV-2 NAbs in combating the COVID-19 pandemic, available detection methods, challenges in developing a POCT, and product applications. It concludes that a widely accessible NAbs POCT is urgently needed.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2021)

Add to Collection

Letter Infectious Diseases

SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity

Muthukumar Ramanathan et al.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection

Article Biochemical Research Methods

Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays

Kevin R. Bewley et al.

Summary: The protocol from Public Health England discusses the use of three assays to measure neutralizing antibodies against SARS-CoV-2 for assessing COVID-19 vaccine efficacy. The PRNT is considered the gold standard for measuring levels of neutralizing antibodies, while the MNA and PNA offer advantages in terms of assay time, throughput, and operator workload. These assays have been critical in the development and licensure of COVID-19 vaccines and are important for demonstrating bioequivalence of future vaccines.

NATURE PROTOCOLS (2021)

Add to Collection

Review Microbiology

SARS-CoV-2 variants, spike mutations and immune escape

William T. Harvey et al.

Summary: The evolution of SARS-CoV-2 has been characterized by the emergence of mutations and variants that impact virus characteristics. Manufacturers are preparing for possible updates to vaccines in response to changes in the virus population, and it is crucial to monitor genetic and antigenic changes alongside experiments to understand the impacts of mutations.

NATURE REVIEWS MICROBIOLOGY (2021)

Add to Collection

Article Cell Biology

A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma

Craig Fenwick et al.

Summary: The study presents a cell-free quantitative neutralization assay for SARS-CoV-2 spike protein, achieving high sensitivity and specificity in assessing neutralizing activities against various variants. The assay can effectively evaluate neutralizing antibody responses to SARS-CoV-2 spike protein variants of concern and characterize vaccine-induced antibody responses or assess the potency of monoclonal antibodies.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Engineering, Biomedical

Rapid single-molecule detection of COVID-19 and MERS antigens via nanobody-functionalized organic electrochemical transistors

Keying Guo et al.

Summary: This study introduces organic electrochemical transistors functionalized with antigen-specific nanobodies for rapid and sensitive protein detection in complex bodily fluids. The sensors demonstrate high specificity and sensitivity, and can be reprogrammed to detect any protein antigen if a specific nanobody is available.

NATURE BIOMEDICAL ENGINEERING (2021)

Add to Collection

Article Medicine, Research & Experimental

A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies

Patthara Kongsuphol et al.

Summary: An easy-to-use, rapid cellulose-based test has been developed to detect neutralizing antibodies against SARS-CoV-2, providing results in just 10 minutes with comparable performance to lab-based tests. This test could be valuable for large-scale monitoring of immunity, especially in populations without routine access to a laboratory.

COMMUNICATIONS MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis

Jennifer M. Zupancic et al.

Summary: There is a strong interest in developing effective methods for generating neutralizing antibodies and nanobodies against SARS-CoV-2. This study presents a simple directed evolution method for producing nanobodies with high affinities and neutralization activities, which can effectively neutralize both SARS-CoV-2 pseudovirus and live virus.

CELL CHEMICAL BIOLOGY (2021)

Add to Collection

Article Pharmacology & Pharmacy

Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS-CoV-2 Variants

Jennifer M. Zupancic et al.

Summary: A novel multivalent nanobody, VHH-72, has shown significant neutralizing activity against various SARS-CoV-2 variants with high biophysical stability, solubility, and specificity.

ADVANCED THERAPEUTICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

Daniel Wrapp et al.

CELL (2020)

Add to Collection

Article Immunology

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

Wanbo Tai et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Add to Collection

Article Infectious Diseases

Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients

J. Van Elslande et al.

CLINICAL MICROBIOLOGY AND INFECTION (2020)

Add to Collection

Article Immunology

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

Xiaolong Tian et al.

EMERGING MICROBES & INFECTIONS (2020)

Add to Collection

Article Multidisciplinary Sciences

Structure of the nCoV trimeric spike

Valda Vinson

SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV

Meng Yuan et al.

SCIENCE (2020)

Add to Collection

Article Virology

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays

Katharine H. D. Crawford et al.

VIRUSES-BASEL (2020)

Add to Collection

Article Multidisciplinary Sciences

A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2

Rui Shi et al.

NATURE (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction

Chee Wah Tan et al.

NATURE BIOTECHNOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation

Antonio E. Muruato et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Multidisciplinary Sciences

An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction

Leo Hanke et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Microbiology

Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding

James R. Byrnes et al.

MSPHERE (2020)

Add to Collection

Article Medicine, Research & Experimental

A simple protein-based surrogate neutralization assay for SARS-CoV-2

Kento T. Abe et al.

JCI INSIGHT (2020)

Add to Collection

Article Biophysics

Rapid and quantitative detection of SARS-CoV-2 specific IgG for convalescent serum evaluation

Xiaotian Tan et al.

BIOSENSORS & BIOELECTRONICS (2020)

Add to Collection

Article Multidisciplinary Sciences

Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2

Yufei Xiang et al.

SCIENCE (2020)

Add to Collection

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients

Nisreen M. A. Okba et al.

EMERGING INFECTIOUS DISEASES (2020)

Add to Collection

Article Biochemical Research Methods

Multiparameter urine analysis for quantitative bladder cancer surveillance of orthotopic xenografted mice

Xiaotian Tan et al.

LAB ON A CHIP (2020)

Add to Collection

Article Biology

COVID19 antibody detection using lateral flow assay tests in a cohort of convalescent plasma donors

Brett Ragnesola et al.

BMC RESEARCH NOTES (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2

Guangyu Zhou et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)

Add to Collection

Article Immunology

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2

Jianhui Nie et al.

EMERGING MICROBES & INFECTIONS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Yeast surface display platform for rapid discovery of conformationally selective nanobodies

Conor McMahon et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)

Add to Collection

Article Multidisciplinary Sciences

A peptide tag-specific nanobody enables high-quality labeling for dSTORM imaging

David Virant et al.

NATURE COMMUNICATIONS (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Yeast surface display platform for rapid discovery of conformationally selective nanobodies

Conor McMahon et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)

Add to Collection

Article Chemistry, Multidisciplinary

Rapid Mouse Follicle Stimulating Hormone Quantification and Estrus Cycle Analysis Using an Automated Microfluidic Chemiluminescent ELISA System

Xiaotian Tan et al.

ACS SENSORS (2018)

Add to Collection

Article Chemistry, Analytical

Glass capillary based microfluidic ELISA for rapid diagnostics

Xiaotian Tan et al.

ANALYST (2017)

Add to Collection

Article Oncology

Efficient cancer therapy with a nanobody-based conjugate

V Cortez-Retamozo et al.

CANCER RESEARCH (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.